Answers are grounded in this paper and cite their sources.
Cohort study identifies baseline metrics predicting retinal nonperfusion in diabetic retinopathy, suggesting new biomarkers.
In this cohort, baseline UWF-FA nonperfusion was the strongest predictor of retinal nonperfusion progression, whereas macular DCP OCTA metrics provided independent, noninvasive prognostic information. Macular DCP OCTA parameters may serve as adjunctive biomarkers to refine DR risk stratification, particularly when UWF-FA is unavailable.
No takes yet. Share an insight, caveat, or question.
Busza et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: